AAPS 2017 Poster: Enabling Clinical Assessment of Maralixibat for Rare Pediatric Liver Disease via Real Time Adaptive GMP Manufacturing
22 November 2017
Overview
A flexible, real-time adaptive GMP manufacturing model is required to support the increasing requirement for clinical trials conducted in small patient populations with challenging trial designs and treatment algorithms.
Download and read our poster titled, 'Enabling Clinical Assessment of Maralixibat for Rare Pediatric Liver Disease via Real-Time Adaptive GMP Manufacturing' here.